Center-Authored Papers

Filters: Author is Rodriguez, Gustavo C  [Clear All Filters]
2017
Phelan CM, Kuchenbaecker KB, Tyrer JP, Kar SP, Lawrenson K, Winham SJ, Dennis J, Pirie A, Riggan MJ, Chornokur G et al..  2017.  Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.. Nature genetics. Abstract
Skates SJ, Greene MH, Buys SS, Mai PL, Brown PH, Piedmonte M, Rodriguez GC, Schorge JO, Sherman M, Daly MB et al..  2017.  Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract
2016
Hollestelle A, van der Baan FH, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Anton-Culver H et al..  2016.  No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology. 141(2):386-401. Abstract
2015
Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM et al..  2015.  Identification of six new susceptibility loci for invasive epithelial ovarian cancer.. Nature genetics. 47(2):164-71. Abstract
2013
Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE et al..  2013.  Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.. Nature genetics. 45(4):371-84,384e1-2. Abstract
2011
Skates SJ, Mai P, Horick NK, Piedmonte M, Drescher CW, Isaacs C, Armstrong DK, Buys SS, Rodriguez GC, Horowitz IR et al..  2011.  Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status.. Cancer prevention research (Philadelphia, Pa.). 4(9):1401-8. Abstract